Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Ann Surg Oncol. 2024 May;31(5):3073-3083. doi: 10.1245/s10434-024-14944-3. Epub 2024 Feb 5.
Ann Surg Oncol. 2024.
PMID: 38316732
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors.
Zeng ZX, Wu JY, Wu JY, Li YN, Fu YK, Zhang ZB, Liu DY, Li H, Ou XY, Zhuang SW, Yan ML.
Zeng ZX, et al.
Hepatol Int. 2024 Apr;18(2):651-660. doi: 10.1007/s12072-023-10613-x. Epub 2023 Dec 1.
Hepatol Int. 2024.
PMID: 38040945
Item in Clipboard
Cite
Cite